Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis

Author:

Zacharias Harry D1,Kamel Fady1,Tan Jaclyn2,Kimer Nina3,Gluud Lise Lotte4,Morgan Marsha Y1

Affiliation:

1. UCL Institute for Liver & Digestive Health; Division of Medicine, Royal Free Campus, University College London; London UK

2. UCL Institute for Liver & Digestive Health, Division of Medicine, Royal Free Campus, University College London; London UK

3. Gastrounit; Medical Division, Copenhagen University Hospital Hvidovre; Hvidovre Denmark

4. Gastrounit, Medical Division; Copenhagen University Hospital Hvidovre; Hvidovre Denmark

Publisher

Wiley

Subject

Pharmacology (medical)

Reference424 articles.

1. Lactulose alone versus lactulose + rifaximin for the management of hepatic encephalopathy;Ahmed;Pakistan Journal of Medical and Health Sciences,2018

2. Efficacy of rifaximin in prevention of recurrence of hepatic encephalopathy in patients with cirrhosis of liver;Ali;Journal of the College of Physicians and Surgeons Pakistan,2014

3. Rifaximin versus placebo preventing the recurrence of clinically overt hepatic encephalopathy in patients having cirrhosis of liver;Babar;Medical Forum,2017

4. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy;Bajaj;Gastroenterology,2011

5. Rifaximin in minimal hepatic encephalopathy clinicaltrials.gov/ct2/show/NCT00533910

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3